Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Egbertson
Erik Egbertson, Medford, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080249749 | INTERACTIVE TRUSS OBJECTS IN COMPUTER-AIDED DESIGN MODELS - Embodiments of the invention provide a computer-aided design (CAD) application configured for generating interactive truss objects in a CAD model. In one embodiment, a truss creation tool allows the user to select a truss family and the endpoints of the truss. Based on these selections, the truss creation tool generates a layout and structural members of a truss. The truss may be maintained as an interactive object within the CAD model. Thus, a user may edit the truss object, resulting in the regeneration of the truss layout and the regeneration of the structural elements of the truss. | 10-09-2008 |
Melissa Egbertson, Ambler, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090054399 | HIV INTEGRASE INHIBITORS - Tricyclic compounds of Formula (I) are inhibitors of HIV integrase and inhibitors of HIV replication: wherein bond a, ring A, R | 02-26-2009 |
Melissa S. Egbertson, Ambler, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080287394 | Hiv Integrase Inhibitors - Hydroxy-substituted pyrazinopyrrolopyridazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I) wherein R | 11-20-2008 |
| 20100298342 | Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease - The present invention is directed to spiropiperidine compounds of formula (I) and tautomers thereof, which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved. | 11-25-2010 |